Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Short Interest Up 92.3% in July

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totaling 877 shares, an increase of 92.3% from the July 15th total of 456 shares. Based on an average daily trading volume, of 1,618 shares, the short-interest ratio is presently 0.5 days. Approximately 0.3% of the shares of the stock are short sold.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

A number of institutional investors have recently made changes to their positions in the company. Comprehensive Wealth Management LLC raised its stake in Innovator IBD Breakout Opportunities ETF by 122.0% in the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after purchasing an additional 12,859 shares during the last quarter. Susquehanna International Group LLP boosted its stake in Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares during the last quarter. Finally, Osaic Holdings Inc. boosted its stake in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after purchasing an additional 597 shares during the last quarter.

Innovator IBD Breakout Opportunities ETF Trading Up 1.3%

NYSEARCA:BOUT opened at $45.26 on Tuesday. The stock has a 50 day moving average of $46.83 and a two-hundred day moving average of $43.81. Innovator IBD Breakout Opportunities ETF has a 12 month low of $35.05 and a 12 month high of $49.41. The firm has a market cap of $15.84 million, a P/E ratio of 28.69 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.